About: Liposomes as immunological adjuvants

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Liposomes as immunological adjuvants Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published in Nature

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) article publié dans la revue scientifique Nature (fr) scientific article published in Nature (en) im November 1974 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в Nature в листопаді 1974 (uk)
publication date	wds:Q59068902-0C0931DC-A839-49C8-8142-6F40C1467875
publication date	1974-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59068902-277F6225-C719-41E9-8FFE-4C0476F7D71A
language of work or name	English
exact match	wds:Q59068902-2CA22900-08F8-479F-89BD-79A6491BAE23
exact match	https://scigraph.springernature.com/pub.10.1038/252252a0
cites work	wds:Q59068902-3A3279CC-83EE-4FD8-94AD-71BD70F22CA1 wds:Q59068902-A317E338-7DC4-45A5-B17D-56B43E0DF074 wds:Q59068902-EDA5671F-D348-46E2-AD12-746EA36E91F5 wds:Q59068902-F44BF2FE-557B-40AD-B2BA-2C8A62C13AAA
cites work	Drug-carrier potential of liposomes in cancer chemotherapy Enzyme-containing Liposomes alleviate a Model for Storage Disease Guanyl cyclase in rat brain subcellular fractions. Immunological reactions with chromic chloride-treated erythrocytes
author name string	wds:Q59068902-18AA65D5-36D4-4A88-82BB-B602D1409DB5 wds:Q59068902-3ACBBCD9-1805-4CB0-B0CF-5B39B7F70EA6
author name string	G Gregoriadis A G Allison
rdfs:label	Liposomes as immunological adjuvants (en) Liposomes as immunological adjuvants (nl)
skos:prefLabel	Liposomes as immunological adjuvants (en) Liposomes as immunological adjuvants (nl)
name	Liposomes as immunological adjuvants (en) Liposomes as immunological adjuvants (nl)
title	wds:Q59068902-14CC0867-C907-42DA-BCBF-143A9AC6A0A1
title	Liposomes as immunological adjuvants (en)
page(s)	wds:Q59068902-941AACAD-E313-4504-A754-7C580B914B54
page(s)	252
instance of	wds:Q59068902-DAF84C4D-3DD9-4702-A1E3-917431EE9A55
instance of	scholarly article
main subject	wds:Q59068902-B416F5FA-24FE-4B09-9576-6D4B4DE95557
main subject	immunology
PubMed ID	wds:Q59068902-E5903D85-61FD-464F-96C1-01567394EE1E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4424229
PubMed ID	4424229
published in	wds:Q59068902-9714F9AD-26BF-46FD-BCF3-03813753A94F
published in	Nature
issue	wds:Q59068902-6039FBAA-196A-49FB-A31F-80A526F26090
volume	wds:Q59068902-BA349B4D-DB9C-4AC7-B42B-05DA2D68929C
issue	5480
volume	252
DOI	wds:Q59068902-4F110C38-3398-41B9-BD9D-860E93CC6072
DOI	http://dx.doi.org/10.1038/252252A0
DOI	10.1038/252252A0
Dimensions Publication ID	wds:Q59068902-3C5767B5-2291-401C-93FB-3698D52033CC
Dimensions Publication ID	1014479808
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59068902
is cites work of	Vaccine adjuvants: current state and future trends Liposome research in drug delivery: the early days. Cytokine mediated effects in mucosal immunity Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens Vaccine adjuvants revisited Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults. Engineering liposomes for drug delivery: progress and problems TRPM2 links oxidative stress to NLRP3 inflammasome activation Lipid vesicles as carriers for introducing biologically active materials into cells Nasal delivery of vaccines Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators Promising particle-based vaccines in cancer therapy. Association of gross virus-associated cell-surface antigen with liposomes Liposomes as drug carriers Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines Monosialoganglioside liposome-entrapped enzyme uptake by hepatic cells Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination Liposome-based cationic adjuvant formulations (CAF): past, present, and future Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype. Immunity, vaccination and the avian intestinal tract Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates. Formation of virosomes from influenza subunits and liposomes Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages Homing of liposomes to target cells Liposomes in immunology: Evidence that their adjuvant effect results from surface exposition of the antigens Evaluation of immunogenicity and protective efficacy of a liposome containing Brucella abortus S19 outer membrane protein in BALB/c mice Immune response mediated by liposome-associated protein antigens. I. Potentiation of the plaque-forming cell response. Liposome potentiation of humoral immune response to lipopolysaccharide and O-polysaccharide antigens of Brucella abortus Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs) Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity Liposomes as nanomedical devices Cationic liposomes as vaccine adjuvants Various carrier system(s)- mediated genetic vaccination strategies against malaria

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software